21 Years of Impact was made possible by the support of our amazing community. And there is such hope for change. Don’t you feel it! Here at HER, we are ready for a BIG day in the nonprofit world: Giving Tuesday, November 30, 2021. Giving Tuesday (GT) is the largest giving day of the year,…
Read MoreThe HER Foundation is thankful for our business partners who support our mission.
Read More
HER Board members, Marlena Fejzo, PhD, and Patrick Mullen, MD, are running the first study of GDF15 in HG patients in the United States.
Read MoreWe created this tool to help guide HG patients through the steps of self advocacy.
Read MoreHyperemesis Gravidarum (HG) is a risk factor for premature birth. HG is defined as a potentially life-threatening pregnancy disease that may cause weight loss, malnutrition, dehydration, and debility due to severe nausea and/or vomiting, and may cause long-term health issues for mother and baby(ies). Did you know: 15% of HG pregnancies result in premature birth…
Read MoreJoin us in honoring Maria and her twins on Thursday, November 25th. Maria’s voice was silenced due to preventable complications of HG, and we all must be a voice for her. No mother should be silenced by HG! On November 25th, share a selfie with your right index finger in the air to indicate 1 MOM is…
Read MoreMarlena Fejzo, PhD, HER Board Member and Research Advisor, presents at the American Society of Human Genetics Annual Meeting on the genetics of Hyperemesis Gravidarum (HG). Title of presentation: “Whole-exome sequencing confirms GDF15 is the greatest genetic risk factor for Hyperemesis Gravidarum and Identifies Rare and Novel Variants in appetite genes GDF15 and GFRAL” Conclusions…
Read More2021 Dormuth CR, Winquist B, Fisher A, et al. Comparison of Pregnancy Outcomes of Patients Treated With Ondansetron vs Alternative Antiemetic Medications in a Multinational, Population-Based Cohort “This meta-analysis of cohort studies of 456,963 pregnancies in 3 countries published in JAMA, found treatment with ondansetron was not significantly associated with increased risk of fetal death,…
Read MoreThe HER Foundation is 21! The Hyperemesis Education and Research Foundation’s mission is to provide Hyperemesis Gravidarum (HG) support, advocacy, education, and research to improve treatment and outcomes. Here’s a listicle to celebrate 21 of the many ways HER has supported families! Launch the first website on HG to educate about treatment options, help those suffering from HG, and…
Read MoreDr. Marlena Fejzo, a geneticist at the University of Southern California and a HER Foundation Board of Directors, presented at the Fetal Medicine Foundation (FMF) about Hyperemesis Gravidarum (HG), its potential causes, and treatment options. Over 5600 medical professionals heard her speak, and the talk is freely available on the FMF’s website in English, Spanish,…
Read More